Rituximab maintenance significantly prolongs progression ‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - November 25, 2018 Category: Hematology Authors: Pavel Klener, David Salek, Robert Pytlik, Heidi Mocikova, Kristina Forsterova, Petra Blahovcova, Vit Campr, Vit Prochazka, Ales Obr, Radek Jaksa, Jana Kuntscherova, Ludmila Boudov á, Roman Kodet, Andrea Janikova, Marek Trneny Tags: CORRESPONDENCE Source Type: research